201 related articles for article (PubMed ID: 18364263)
1. An investigation of the differential expression of Her2/neu gene expression in normal oral mucosa, epithelial dysplasia, and oral squamous cell carcinoma in Taiwan.
Fong Y; Chou SJ; Hung KF; Wu HT; Kao SY
J Chin Med Assoc; 2008 Mar; 71(3):123-7. PubMed ID: 18364263
[TBL] [Abstract][Full Text] [Related]
2. Salivary Her2/neu Levels in Differentiation of Oral Premalignant Disorders and Oral Squamous Cell Carcinomas.
Varun C; Dineshkumar T; Jayant VS; Rameshkumar A; Rajkumar K; Rajashree P; Mathew J; Arunvignesh RK
Asian Pac J Cancer Prev; 2015; 16(14):5773-7. PubMed ID: 26320450
[TBL] [Abstract][Full Text] [Related]
3. Lack of elevated HER2/neu expression in epithelial dysplasia and oral squamous cell carcinoma in Iran.
Seifi S; Shafaei SN; Nosrati K; Ariaeifar B
Asian Pac J Cancer Prev; 2009; 10(4):661-4. PubMed ID: 19827890
[TBL] [Abstract][Full Text] [Related]
4. Loss of ELF3 immunoexpression is useful for detecting oral squamous cell carcinoma but not for distinguishing between grades of epithelial dysplasia.
AbdulMajeed AA; Dalley AJ; Farah CS
Ann Diagn Pathol; 2013 Aug; 17(4):331-40. PubMed ID: 23643910
[TBL] [Abstract][Full Text] [Related]
5. p73 expression for human buccal epithelial dysplasia and squamous cell carcinoma: does it correlate with nodal status of carcinoma and is there a relationship with malignant change of epithelial dysplasia?
Chen YK; Hsue SS; Lin LM
Head Neck; 2004 Nov; 26(11):945-52. PubMed ID: 15390192
[TBL] [Abstract][Full Text] [Related]
6. Increased expression of MCM5 is significantly associated with aggressive progression and poor prognosis of oral squamous cell carcinoma.
Yu SY; Wang YP; Chang JY; Shen WR; Chen HM; Chiang CP
J Oral Pathol Med; 2014 May; 43(5):344-9. PubMed ID: 24245508
[TBL] [Abstract][Full Text] [Related]
7. Immunohistochemical study of p53 and angiogenesis in benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Abbas NF; Labib El-Sharkawy S; Abbas EA; Abdel Monem El-Shaer M
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Mar; 103(3):385-90. PubMed ID: 17321451
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of p53 and p63 in oral squamous cell carcinoma, oral leukoplakia, and oral submucous fibrosis.
Varun BR; Ranganathan K; Rao UK; Joshua E
J Investig Clin Dent; 2014 Aug; 5(3):214-9. PubMed ID: 23776093
[TBL] [Abstract][Full Text] [Related]
9. Clinical significance of aberrant vimentin expression in oral premalignant lesions and carcinomas.
Sawant SS; Vaidya Mm; Chaukar DA; Alam H; Dmello C; Gangadaran P; Kannan S; Kane S; Dange PP; Dey N; Ranganathan K; D'Cruz AK
Oral Dis; 2014 Jul; 20(5):453-65. PubMed ID: 23865921
[TBL] [Abstract][Full Text] [Related]
10. MCM3 could be a better marker than Ki-67 for evaluation of dysplastic oral lesions: an immunohistochemical study.
Lameira AG; Pontes FS; Guimarães DM; Alves AC; de Jesus AS; Pontes HA; Pinto Ddos S
J Oral Pathol Med; 2014 Jul; 43(6):427-34. PubMed ID: 24456424
[TBL] [Abstract][Full Text] [Related]
11. Differential expression of E-cadherin in metastatic lesions comparing to primary oral squamous cell carcinoma.
Hung KF; Chang CS; Liu CJ; Lui MT; Cheng CY; Kao SY
J Oral Pathol Med; 2006 Nov; 35(10):589-94. PubMed ID: 17032390
[TBL] [Abstract][Full Text] [Related]
12. Expression of Gα12 predicts progression and prognosis of oral squamous cell carcinomas in Taiwan.
Cheng SJ; Liu YC; Cheng SL; Lee JJ; Chen HM; Chang HH; Kok SH; Kuo MY; Chiang CP
J Oral Pathol Med; 2013 Aug; 42(7):565-9. PubMed ID: 23438080
[TBL] [Abstract][Full Text] [Related]
13. Expression of hepatocyte growth factor and c-met protein is significantly associated with the progression of oral squamous cell carcinoma in Taiwan.
Chen YS; Wang JT; Chang YF; Liu BY; Wang YP; Sun A; Chiang CP
J Oral Pathol Med; 2004 Apr; 33(4):209-17. PubMed ID: 15061708
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical study of MUC1 mucin in premalignant oral lesions and oral squamous cell carcinoma: association with disease progression, mode of invasion, and lymph node metastasis.
Nitta T; Sugihara K; Tsuyama S; Murata F
Cancer; 2000 Jan; 88(2):245-54. PubMed ID: 10640953
[TBL] [Abstract][Full Text] [Related]
15. The biphasic differential expression of the cellular membrane protein, caveolin-1, in oral carcinogenesis.
Hung KF; Lin SC; Liu CJ; Chang CS; Chang KW; Kao SY
J Oral Pathol Med; 2003 Sep; 32(8):461-7. PubMed ID: 12901727
[TBL] [Abstract][Full Text] [Related]
16. Her2 expression and gene amplification is rarely detectable in patients with oral squamous cell carcinomas.
Hanken H; Gaudin R; Gröbe A; Fraederich M; Eichhorn W; Smeets R; Simon R; Sauter G; Grupp K; Izbicki JR; Sehner S; Heiland M; Blessmann M
J Oral Pathol Med; 2014 Apr; 43(4):304-8. PubMed ID: 24645976
[TBL] [Abstract][Full Text] [Related]
17. Expression of Mcm2, geminin and Ki67 in normal oral mucosa, oral epithelial dysplasias and their corresponding squamous-cell carcinomas.
Torres-Rendon A; Roy S; Craig GT; Speight PM
Br J Cancer; 2009 Apr; 100(7):1128-34. PubMed ID: 19293805
[TBL] [Abstract][Full Text] [Related]
18. Apoptosis resistance-related ABCB5 and DNaseX (Apo10) expression in oral carcinogenesis.
Grimm M; Cetindis M; Lehmann M; Biegner T; Munz A; Teriete P; Reinert S
Acta Odontol Scand; 2015 Jul; 73(5):336-42. PubMed ID: 25234444
[TBL] [Abstract][Full Text] [Related]
19. Expression of hypoxia-inducible factor-1 alpha is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan.
Lin PY; Yu CH; Wang JT; Chen HH; Cheng SJ; Kuo MY; Chiang CP
J Oral Pathol Med; 2008 Jan; 37(1):18-25. PubMed ID: 18154573
[TBL] [Abstract][Full Text] [Related]
20. Expression of HER-2/neu in Oral Squamous Cell Carcinoma.
Mirza S; Hadi N; Pervaiz S; Zeb Khan S; Mokeem SA; Abduljabbar T; Al-Hamoudi N; Vohra F
Asian Pac J Cancer Prev; 2020 May; 21(5):1465-1470. PubMed ID: 32458657
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
